LONDON, April 22, 2014 /PRNewswire/ --
The US markets saw a positive sentiment on Monday, April 21, 2014, with the NASDAQ Composite closing at 4,121.55, up 0.64%, the Dow Jones Industrial Average ending the session at 16,449.25, up 0.25%, and the S&P 500 gained 0.38%, to finish the trading session at 1,871.89. The gains were broad based as eight out of ten sectors ended the session in positive. A number of stocks saw large movements, including Sky-mobi Ltd (NASDAQ: MOBI), China Ming Yang Wind Power Group Ltd (NYSE: MY), Synthetic Biologics Inc. (NYSE MKT: SYN) and TearLab Corp. (NASDAQ: TEAR). Free technical research on MOBI, MY, SYN and TEAR can be downloaded upon signing up at:
On Monday, shares in Sky-mobi Ltd ended the session at $7.68, up 8.32%. A total of 1.15 million shares were traded, which is above its three months average volume of 0.92 million shares. The company's stock traded between $7.03 and $8.00 during the trading session. Shares in Sky-mobi Ltd have rallied 12.53% in the previous three trading session, 54.84% in the last three months, and 106.45% on YTD basis. The S&P 500 Information Technology Sector Index mapped a gain of 0.44% during the trading session, and the same has charted up 1.18% in the previous three trading sessions. Further, the company's stock traded at PE ratio of 47.24 and has a Relative Strength Index (RSI) of 40.78. The company's stock is trading above its 50-day and 200-day moving average of $7.64 and $4.87, respectively. Sign up today to read free research on MOBI at:
Shares in China Ming Yang Wind Power Group Ltd's closed Monday's session at $2.71, which is 7.97% higher than its previous day's closing price of $2.51. The stock oscillated between $2.52 and $2.73 during the trading session with a trading volume of 1.06 million shares, which is below its three months average volume of 2.03 million shares. Shares in China Ming Yang Wind Power Group Ltd have advanced 5.86% in the previous three trading session, and 10.61% on YTD basis. The S&P 500 Industrials Sector Index mapped a gain of 0.32% during the trading session, and the same has advanced 2.67% in the previous three trading sessions. Moreover, the company's stock has an RSI of 39.87 and is trading above its 200-day moving average of $2.40. Sign up today to read free research on MY at:
On Monday, Synthetic Biologics Inc.'s stock surged 14.29%, finishing at $2.88. The stock fluctuated between $2.50 and $2.90 during the session with a trading volume of 1.20 million shares as compared with its three months average volume of 1.37 million shares. Shares in Synthetic Biologics Inc. have rallied 16.13% in the previous three trading sessions, 54.01 % in the last three months, and 88.24% on YTD basis. The S&P 500 Health Care Sector Index mapped a gain of 1.20% during the trading session, and the same has gained 1.75% in the previous three trading sessions. Furthermore, the company's stock has an RSI of 47.02 and is trading above its 50-day and 200-day moving averages of $2.64 and $1.83, respectively. Sign up today to read free research on SYN at:
Shares in TearLab Corp. finished Monday's session at $5.25, up 13.39%. A total of 1.01 million shares were traded, which is above its three months average volume of 0.48 million shares. The stock vacillated between $4.65 and $5.36 during the trading session. TearLab Corp.'s shares have declined 2.60% in the previous three trading sessions, and 43.79% on YTD basis. The S&P 500 Health Care Sector Index mapped a gain of 0.90% in the previous three months, while the S&P 500 has advanced 1.81% during the same period. Additionally, the company's stock has an RSI of 19.17 and is trading below its 50-day and 200-day moving averages of $6.88 and $9.79, respectively. Sign up today to read free research on TEAR at:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.